Companies
Runke Biological
founded May 2000 in Shantou, Guangdong; China's #1 (40.73% domestic share) and global #2 microalgae DHA producer (global top-3); Fujian Zhao'an base (320 mu, since 2008) is its largest DHA plant; its central lab earned CNAS national accreditation in January 2026, with FDA GRAS, EU Novel Food,…
- Country
- China
FDA GRAS / EU novel food
CNAS-accredited lab
CN #1 algal DHA (40.7%)
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| marine-biotech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | 221 million RMB (2023 Q3) | qiye.qizhidao.com |
| Headcount | 50-99 people (2025) | m.qcc.com |
| Production site | Guangdong Peizhi base, Fujian Runke production base | runke.com.cn |
| Certification | FSSC22000, IP non-GMO certification | runke.com.cn |
| Regulatory approval | ISO series, ISO22000, HACCP, GMP, FDA registration and GRAS safety certification, EU novel food certification | m.chinairn.com |
Independent sources: m.chinairn.com · m.qcc.com · qiye.qizhidao.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Marine biotechnology | marine-biotech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.